<DOC>
	<DOCNO>NCT02532023</DOCNO>
	<brief_summary>The aim study determine effect omega 3 fatty acid , curcumin combination placebo 2 month gene expression COX-2 , iNOS , TNF-α , IL-1β , IL-6 , VCAM-1 ICAM-1 peripheral blood mononuclear cell ( PBMC ) serum level COX-2 , iNOS , TNF-α , IL-1β , IL-6 , VCAM-1 , ICAM-1 hsCRP migraine patient .</brief_summary>
	<brief_title>The Combined Effects omega3 Fatty Acids Curcumin Supplementation Inflammatory Endothelial Factors Migraine Patients</brief_title>
	<detailed_description>The aim study determine effect omega 3 fatty acid , curcumin combination placebo 2 month gene expression cyclooxygenase-2 ( COX-2 ) , inducible nitric oxide synthase ( iNOS ) , Tumor necrosis factor-α ( TNF-α ) , interleukin-1β ( IL-1β ) , interleukin-6 ( IL-6 ) , vascular cell adhesion molecule-1 ( VCAM-1 ) intercellular adhesion molecule-1 ( ICAM-1 ) peripheral blood mononuclear cell ( PBMC ) serum level COX-2 , iNOS , TNF-α , IL-1β , IL-6 , VCAM-1 , ICAM-1 high-sensitivity C-reactive protein ( hsCRP ) migraine patient . In randomized , double-blind clinical trial , placebo-controlled study , 80 woman men migraine enrol Iranian Center Neurological Research . At start study , participant sign inform consent complete general information form . 24-hour food recall 3 day take patient begin end study . Selected sample use stratified randomization method base sex , gender body mass index ( BMI ) classify 4 group : 1 ) receive omega 3 fatty acid supplement curcumin supplement 2 ) receive omega 3 fatty acid supplement curcumin placebo 3 ) receive curcumin supplement omega 3 fatty acid placebo 4 ) receive omega 3 fatty acid placebo curcumin placebo . The omega 3 fatty acid supplement group receive 1200 mg Eicosapentaenoic acid ( EPA ) 600 mg Docosahexaenoic acid ( DHA ) totally 1800 mg daily 2 month . The curcumin supplement group receive 1000 mg curcumin daily 2 month . The omega 3 fatty acid placebo group also receive placebo containing 1800 mg edible paraffin oil curcumin placebo group receive 1000 mg starch powder similar term color , shape size . participant advise maintain diet , level physical activity medication dose study . Blood sample collect anthropometric parameter measure target biochemical parameter , gene expression serum level physical activity measure trial .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>migraine patient 20 50 year old body mass index 18.5 avoidance dietary supplement , vitamin herbal product least 46 week throughout intervention willingness participation sensitivity omega 3 fatty acid curcumin pregnancy lactation sever change regular diet life style change type dosage regular medication ( ) inflammatory disease need take anti inflammatory drug 2 week</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>omega 3 fatty acid</keyword>
	<keyword>curcumin</keyword>
	<keyword>COX-2</keyword>
	<keyword>iNOs</keyword>
	<keyword>VCAM-1</keyword>
	<keyword>ICAM-1</keyword>
	<keyword>IL-1β</keyword>
	<keyword>IL-6</keyword>
	<keyword>TNF-α</keyword>
	<keyword>hsCRP</keyword>
	<keyword>migraine</keyword>
</DOC>